These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26051589)

  • 1. Developing vaccines to prevent malaria in pregnant women.
    Tuikue-Ndam N; Deloron P
    Expert Opin Biol Ther; 2015; 15(8):1173-82. PubMed ID: 26051589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and new horizons toward a VAR2CSA-based placental malaria vaccine.
    Doritchamou JYA; Suurbaar J; Tuikue Ndam N
    Expert Rev Vaccines; 2021 Feb; 20(2):215-226. PubMed ID: 33472449
    [No Abstract]   [Full Text] [Related]  

  • 3. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical and clinical development of the first placental malaria vaccine.
    Pehrson C; Salanti A; Theander TG; Nielsen MA
    Expert Rev Vaccines; 2017 Jun; 16(6):613-624. PubMed ID: 28434376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and Insights Toward an Effective Placental Malaria Vaccine.
    Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA
    Front Immunol; 2021; 12():634508. PubMed ID: 33717176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
    Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
    Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a vaccine against pregnancy-associated malaria.
    Tuikue Ndam N; Deloron P
    Parasite; 2008 Sep; 15(3):515-21. PubMed ID: 18814733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.
    Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A
    Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae.
    Gbédandé K; Fievet N; Viwami F; Ezinmegnon S; Issifou S; Chippaux JP; Dossou Y; Moutairou K; Massougbodji A; Ndam N; de Jongh WA; Søgaard TMM; Salanti A; Nielsen MA; Esen M; Mordmüller B; Deloron P; Luty AJF;
    Vaccine; 2017 Jun; 35(27):3474-3481. PubMed ID: 28527688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development.
    Hviid L
    Hum Vaccin; 2010 Jan; 6(1):84-9. PubMed ID: 19823032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
    Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A
    PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin.
    Nielsen MA; Resende M; Alifrangis M; Turner L; Hviid L; Theander TG; Salanti A
    Exp Parasitol; 2007 Sep; 117(1):1-8. PubMed ID: 17442305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria.
    Hviid L
    Expert Rev Vaccines; 2011 Oct; 10(10):1405-14. PubMed ID: 21988306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
    Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
    Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of ID1-DBL2X predicts its validity as a vaccine candidate in Colombia and supports at least two independently introduced Plasmodium falciparum populations in the region.
    Rajwani J; Klinger CM; Arango E; Arroyo MI; Sabbagh A; Maestre A; Dacks JB; Gnidehou S; Yanow SK
    Infect Genet Evol; 2017 Nov; 55():175-185. PubMed ID: 28893687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
    de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
    Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroporation-mediated genetic vaccination for antigen mapping: application to Plasmodium falciparum VAR2CSA protein.
    Bordbar B; Gnidehou S; Ndam NT; Doritchamou J; Moussiliou A; Quiviger M; Deloron P; Scherman D; Bigey P
    Bioelectrochemistry; 2012 Oct; 87():132-7. PubMed ID: 22265101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum.
    Duffy MF; Maier AG; Byrne TJ; Marty AJ; Elliott SR; O'Neill MT; Payne PD; Rogerson SJ; Cowman AF; Crabb BS; Brown GV
    Mol Biochem Parasitol; 2006 Aug; 148(2):117-24. PubMed ID: 16631964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine.
    Gill J; Chakraborti S; Bharti P; Sharma A
    Int J Infect Dis; 2021 Nov; 112():35-39. PubMed ID: 34450283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.